Cited by 16Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Health and Disease PreventionCardiovascular Function and Risk Factors

Prediabetes Is Independently Associated with Subclinical Carotid Atherosclerosis: An Observational Study in a Non-Urban Mediterranean Population

Open access
Vilanova, Maria Belén, Franch-Nadal, Josep, Falguera, Mireia, Marsal, Josep Ramon, Canivell, Sílvia, Rubinat, Esther, Miró, Neus, Molló, Àngels +4 more·2020·Journal of Clinical Medicine

Abstract

This was a prospective, observational study to compare the burden of subclinical atherosclerosis as measured by carotid ultrasonography in a cohort of subjects with prediabetes vs. subjects with normal glucose tolerance (NGT) from a non-urban Mediterranean population. Atherosclerosis was assessed through carotid intima-media thickness (c-IMT), the presence/absence of carotid plaques, and plaque number. Among 550 subjects included, 224 (40.7%) had prediabetes. The mean c-IMT and the prevalence of carotid plaque were significantly higher in the prediabetes group compared to the NGT group (0.72 vs. 0.67 mm, p < 0.001; and 37.9% vs. 19.6%; p < 0.001, respectively). Older age, male gender, and increased systolic blood pressure were positively correlated with c-IMT and were independent predictors of the presence of plaques. In contrast, prediabetes and low-density lipoprotein (LDL)-c were predictors of the presence of plaque (odds ratio [OR] = 1.64; 95% confidence interval [CI] = 1.05–2.57; p = 0.03 and OR = 1.01; 95% CI = 1.00–1.02; p = 0.006, respectively) together with tobacco exposure and the leukocyte count (OR = 1.77; 95% CI = 1.08–2.89; p = 0.023 and OR = 1.20; 95% CI = 1.05–1.38; p = 0.008, respectively). In a non-urban Mediterranean population, prediabetes was associated with established subclinical carotid atherosclerosis. These findings could have implications for the prevention and treatment of CV risk in these subjects before the first symptoms of cardiovascular disease appear.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm9072139

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Diabetic patients face a 2- to 4-fold higher risk of developing CVD compared to the general population, with earlier onset and poorer prognosis.

    “Epidemiological studies reveal that diabetic patients face a 2- to 4-fold higher risk of developing CVD compared to the general population, with earlier onset and poorer prognosis [83, 84].”

    From Artificial intelligence-powered prediction of diabetic complications: from clinical data to molecular omics (2026) · cites this paper as [83]

    The Introduction (page not provided) reports a two- to four-fold higher risk of atherosclerotic CVD and poorer cardiovascular prognosis in people with type 2 diabetes than in people without diabetes. It discusses atherosclerosis beginning during prediabetes, but does not establish that CVD begins earlier in diabetic patients than in the general population. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Vilanova, M. B., Franch-Nadal, J., Falguera, M., Marsal, J. R., Canivell, S., Rubinat, E., Miró, N., Molló, À., Mata-Cases, M., Gratacòs, M., Castelblanco, E., & Mauricio, D.
Affiliations
  • Primary Health Care Center Igualada Nord, Consorci Sanitari de l’Anoia, Servei Català de la Salut, 08700 Igualada, Barcelona, Spain
  • CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III (ISCIII), 28029 Barcelona, Spain
  • Universitat de Lleida (ES)
  • Unitat de Suport a la Recerca, Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), 25198 Lleida, Spain
  • Institut Universitari d'Investigació en Atenció Primària Jordi Gol (ES)
  • Institut Català de la Salut (ES)
  • DAP-Cat group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 08006 Barcelona, Spain
  • Instituto de Salud Carlos III (ES)
Corresponding author
Castelblanco, Esmeralda
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2020-07-07
Volume
9
Issue
7
Pages
2139
ISSN
2077-0383 (ISSN-L)
OpenAlex
W3040454836
Cited by
16
References
53
Citations by year
2026: 3 · 2025: 1 · 2024: 2 · 2023: 2 · 2022: 6 · 2021: 2
FWCI
1.89
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, cc-by)
  • Repositori ObertUDL (University of Lleida) (publishedVersion, cc-by)
  • Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • RECERCAT (Consorci de Serveis Universitaris de Catalunya) (submittedVersion, cc-by)
Funders
  • Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol) (NA)
  • CIBER for Diabetes and Associated Metabolic Diseases (CIBERDEM) (NA)
  • Carlos III National Institute of Health and European Regional Development Fund (PI15/0625 and PI18/0328)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
prediabetes, subclinical atherosclerosis, carotid intima-media thickness, carotid plaque, carotid ultrasound, LDL cholesterol, tobacco smoke exposure, white blood cell count, cardiovascular risk, Mediterranean populations

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review